[Research Report] The oligonucleotide synthesis market was valued at US$ 1,584.16 million in 2018 and the oligonucleotide synthesis market size is projected to reach US$ 3,971.72 million by 2027. It is expected to register a CAGR of 11.1% in the forecast period.
Market Insights and Analyst View:
Oligonucleotide synthesis refers to the synthesis of are short fragments of nucleic acids using genetic engineering and enzyme chemistry. The technique is useful in existing laboratory practice as it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired length and sequence. Oligonucleotides are used from initial research and screening through to target validation and drug production. Today, subsequent improvements in oligonucleotide synthesis, amplification and automation has completely revolutionized biological research. Increasing applications of synthesized oligonucleotides, increasing investments for synthetic biology and technological advancements genome editing tools are the key driving factors for the growth of the market in the forecast period. However, the growth of the market is restrained by factors such as renewed regulations for biotechnology and lack of skilled professionals in life science industry.
Growth Drivers and Opportunities:
Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. There is hardly a field in biology in which synthetic DNA has not been used or does not have the potential to be used. The main reason for such a turnabout is the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques.
Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. Oligonucleotide probes are used to detect single base pair changes within human genome. For instance, sickle cell anemia which is caused by a transversion (A^T) within β-globin gene can be analyzed with labeled oligonucleotides. Under stringent hybridization conditions, it is possible to detect whether one or two of family's alleles contain the mutant gene. Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein).
Oligonucleotides has tremendous potential for treating wide range of medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Oligonucleotide Synthesis Market: Strategic Insights
Market Size Value in US$ 1,584.16 million in 2018 Market Size Value by US$ 3,971.72 million by 2027 Growth rate CAGR of 11.1% from 2019 to 2027. Forecast Period 2019-2027 Base Year 2019
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Oligonucleotide Synthesis Market: Strategic Insights
| Market Size Value in | US$ 1,584.16 million in 2018 |
| Market Size Value by | US$ 3,971.72 million by 2027 |
| Growth rate | CAGR of 11.1% from 2019 to 2027. |
| Forecast Period | 2019-2027 |
| Base Year | 2019 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Oligonucleotide Synthesis Market” is segmented based on product, application end user and geography. The product segment of the oligonucleotide synthesis market is broadly segmented into synthesized oligonucleotides, reagents and equipment. The oligonucleotide synthesis market is classified on the basis of application such as research, diagnostics and therapeutics. On basis of end user market is classified into academic research institutes, pharmaceutical & biotechnology companies, diagnostic laboratories, and other end users. The oligonucleotide synthesis market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
The product segment of the oligonucleotide synthesis market is broadly segmented into synthesized oligonucleotides, reagents and equipment. The companies such as Twist Bioscience, Thermo Fisher Scientific Inc., and Agilent Technologies among others are major players in the market for the oligonucleotide synthesis. The synthesized oligonucleotides is the largest segment among the products in the oligonucleotide synthesis market in 2017 and is also anticipated to hold the largest market in the year 2027. In addition to diagnostic and therapeutic purpose, oligonucleotides are also used for designing DNA microchips that are used as a powerful bio-analytical tool and novel material in the field of nanotechnology. Owing to the benefits offered by synthesized oligonucleotides, the demand for the segment is expected to grow significantly during the forecast period.
The oligonucleotide synthesis market is classified on the basis of application such as research, diagnostics and therapeutics. The market is dominated by research segment and is expected to surge significantly during the forecast period. The investments made by countries in R&D activities is expected to fuel the demand of oligonucleotide synthesis during the forecast period. For instance, in Canada, Looking ahead to 2018 and 2021, there was an increase in companies’ expected R&D spending. In both 2018 and 2021, the largest category of R&D spending was around $1 to $5 million. In the field of research, oligonucleotides used for purposes such as, gene knockout, genotyping, and diagnosis typically need further purification after synthesis. Hence, the rise in research activities is expected to offer significant growth opportunities for the oligonucleotide synthesis market in the coming years.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Regional Analysis:
Based on geography, the oligonucleotide synthesis market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. The market of oligonucleotide synthesis in the United States in anticipated to witness significant growth during the forecast period, owing to factors such as, rising investments in the development of pharmaceutical and biotechnology companies, funds from government bodies as well as rise in the number of market players and their focus in the oligonucleotide synthesis market. The increasing investments and rising funds dedicated to the manufacturing companies as well as academic and research institutes for the development of gene synthesis based end products such as precision medicine and other therapeutics is one of the major driving factors. According to an annual industry growth update published by SynBioBeta, a leading community of investors, entrepreneurs, and others, more than US$ 1 Bn was invested in synthetic biology by various companies in the US and worldwide. Additionally, according to a report by National Center for Biotechnology Information (NCBI), US government offers approximately US$220 million every year toward synthetic biology research and development.
Furthermore, Europe oligonucleotide synthesis market includes countries such as France, Germany, Italy, Spain, United Kingdom, and rest of Europe. The region is expected to experience a steady growth rate of 13.7% from 2018 to 2027. The European oligonucleotide synthesis market is expected to witness significant growth during the forecast period, due to factors such as, growing biotechnology industry, partnerships and collaborations undertaken by the market players as well as increasing venture capital investments. In addition, the players operating in the UK oligonucleotide synthesis market have been obtaining funds in order to enhance their product offering. For instance, in March, 2019, UK based privately held biotech company, Procarta Biosystems received a fund of US$ 1.69 Mn (€1.5 m) from the Novo Holdings REPAIR Impact Fund in order to enable the development of novel therapies to combat antimicrobial resistance (AMR). The funding would be utilized to develop a pipeline of a new class of antibiotic precision medicines from Procarta’s exclusive oligonucleotide-based antimicrobial platform. The above mentioned factors are expected to fuel the growth of oligonucleotide synthesis market in UK at a significant rate during the forecast period.
Asia Pacific includes countries such as India, China, Japan, Australia, South Korea, and Rest of Asia Pacific. The market for the oligonucleotide synthesis is expected to grow in these countries due to the growth of biotechnological industry in countries such as, Japan and China, prevalence of cancer as well as strategic developments made by the companies in the Asian market. The above mentioned factors offer significant growth opportunities for oligonucleotide synthesis market during the forecast period. In addition, Chinese government is supporting more for the genetic studies and with the support of local players. The genetic studies in China is booming to the increasing demand for the genetic sequencing. Along with the local players the international players are also investing in the country. For instance, Illumina Inc, has grown its presence in the country and has expanded its headquarters to Shanghai. The company has also introduced its BaseSpace Sequence Hub in China. The extensive genome studies are being assisted with this extended instrument of the Illumina, Inc. the instrument enables to manage and analyze data using a curated set of analysis apps and it includes the cloud base genomics data storage solutions.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global oligonucleotide synthesis market are listed below:
- In July 2022, At its Changzhou site, WuXi STA, a division of WuXi AppTec, unveiled a brand-new large-scale oligonucleotide and peptide manufacturing plant. With this new launch, it will be better able to address the rapidly expanding global demand for oligonucleotide and peptide therapies development and manufacture.
- In April 2022, Bachem entered a strategic collaboration with Eli Lilly & Company to develop and manufacture active pharmaceutical ingredients based on oligonucleotides, a rising new class of complex molecules. Under the agreement, Bachem provides the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology..
Covid-19 Impact:
The market for the synthesis of oligonucleotides has been impacted by COVID-19. The need for oligonucleotide raw materials, which serve as the foundation for molecular diagnostic solutions, has increased because to the rising demand for COVID-19 diagnoses worldwide. It was discovered that the oligonucleotides successfully targeted 5'-polyUs in the coronavirus genome in a study that was published in PLOS One in March 2022. Additionally, reducing the creation and dissemination of new SARS-CoV-2 can be accomplished by creating therapeutic COVID-19 drugs that use crucial mutational sites such the 5'-polyU tract. Such studies have influenced the demand for and use of oligonucleotides in drug development, which has had an impact on the market's expansion during a pandemic. Additionally, a number of businesses are investing in oligonucleotide synthesis, which is anticipated to accelerate market expansion throughout the anticipated period. For instance, SpeeDx made a local oligonucleotide manufacturing investment in September 2021 to lower supply chain risk and provide a more essential sovereign capacity for important diagnostics. As a result of these breakthroughs, oligonucleotides are anticipated to be used more frequently in the production of pharmaceuticals, which is likely to drive market expansion over the next years.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global oligonucleotide synthesis market Molecular Assemblies, Twist Bioscience, Evonetix, Nuclera Nucleics Ltd., Camena Bio, DNA Script, Iridia, Inc., Helixworks, Ansa Biotechnologies, Inc., and Synthomics, Inc., among others. These oligonucleotide companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share. The report offers trend analysis of the oligonucleotide synthesis market emphasizing on various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
The Asia Pacific oligonucleotide synthesis market is expected to grow at highest rate during the forecast period owing to higher number of research & development.
The major key player in oligonucleotide synthesis market are Thermo Fisher Scientific Inc., DNA Script, GenScript, Synthomics, Ansa Biotechnologies, Helixworks, Molecular Assemblies, Keasling Laboratories, Nuclera Nucleics, Camena Bioscience, Evonetix, Twist Biosciences, Iridia
Strategic acquisition and product launches were observed as the most adopted strategy in global oligonucleotide synthesis industry.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 market segmentation
1.3.1 Global Oligonucleotide Synthesis Market – By Product
1.3.2 Global Oligonucleotide Synthesis Market – By Application
1.3.3 Global Oligonucleotide Synthesis Market – By End User
1.3.4 Global Oligonucleotide synthesis Market – By Geography
2. Global Oligonucleotide Synthesis Market – Key takeaways
3. Research Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. Global Oligonucleotide synthesis market – market landscape
4.1 overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Key Market Drivers
4.3.1 Increasing Applications of Synthesized Oligonucleotides
4.3.2 Increasing Investments for Synthetic Biology
4.3.3 Technological Advancements Genome Editing Tools
4.4 Key Market Restraints
4.4.1 Renewed Regulations for Biotechnology
4.4.2 Lack Of Skilled Professionals In Life Science Industry
4.5 Key Market Opportunities
4.5.1 Collaborations — The Future of Innovation
4.6 Future Trends
4.6.1 Advancements in Synthetic Biology
4.7 Impact analysis
5. Oligonucleotide Synthesis market – Global Analysis
5.1 global Oligonucleotide Synthesis market Revenue Forecasts and Analysis
5.2 global Oligonucleotide Synthesis market, By Geography - Forecasts and Analysis
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 GenScript
5.4 expert opinions
6. Global oligonucleotide synthesis market Analysis – By Product
6.1 Overview
6.2 GLOBAL Oligonucleotide synthesis market, BY product, 2018 & 2027 (%)
6.3 Synthesized Oligonucleotides Market
6.3.1 Overview
6.3.2 Global Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.3 Primers Market
6.3.3.1 Overview
6.3.3.2 Global Primers Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4 Probes Market
6.3.4.1 Overview
6.3.4.1.1 Global Probes Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.2 Large-Scale Synthesis Oligonucleotides Market
6.3.4.2.1 Overview
6.3.4.2.2 Global Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.3 Others Market
6.3.4.3.1 Overview
6.3.4.3.2 Global Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Reagents Market
6.4.1 Overview
6.4.2 Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Equipment Market
6.5.1 Overview
6.5.2 Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
7. Global Oligonucleotide synthesis market Analysis – By application
7.1 Overview
7.2 GLOBAL Oligonucleotide synthesis market, BY application, 2018 & 2027 (%)
7.3 research Market
7.3.1 Overview
7.3.2 Global Research Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Diagnostics Market
7.4.1 Overview
7.4.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 therapeutics Market
7.5.1 Overview
7.5.2 Global Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8. Global oligonucleotide synthesis market Analysis – By end user
8.1 Overview
8.2 GLOBAL Oligonucleotide synthesis market, BY end user, 2018 & 2027 (%)
8.3 Academic Research Institutes Market
8.3.1 Overview
8.3.2 Global Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Diagnostic Laboratories Market
8.4.1 Overview
8.4.2 Global Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Pharmaceutical & Biotechnology Companies Market
8.5.1 Overview
8.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Other end users Market
8.6.1 Overview
8.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
9. Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 – Geography analysis
9.1 North America Oligonucleotide synthesis market Revenue and Forecasts to 2027
9.1.1 North America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.2.1 North America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.2.1 US Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 US Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.2.1 Canada Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Canada Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.2.1 Mexico Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 Mexico Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2 Europe Oligonucleotide Synthesis market Revenue and Forecasts to 2027
9.2.1 Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.2 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.2.1 Europe Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.3 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.4 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.5 Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.2.6 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.2 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.6.2.1 UK Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.6.3 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.6.4 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.7 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.2 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.7.2.1 Germany Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.7.3 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.7.4 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.8 France Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.2 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.8.2.1 France Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.8.3 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.8.4 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.9 Italy Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.2 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.9.2.1 Italy Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.9.3 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.9.4 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.2.10 Spain Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.1 Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.2 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.2.10.2.1 Spain Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.2.10.3 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.2.10.4 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3 Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027
9.3.1 Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.2 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.2.1 Asia Pacific Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.3 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.4 Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.5 Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.3.6 China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.1 China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.6.2.1 China Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.6.3 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.6.4 China Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.7 India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.1 India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.7.2 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.7.2.1 India Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.7.3 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.7.4 India Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.8 Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.1 Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.8.2 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.8.2.1 Japan Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.8.3 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.8.4 Japan Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.9 Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.1 Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.9.2 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.9.2.1 Australia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.9.3 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.9.4 Australia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.3.10 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.1 South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.10.2 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.3.10.2.1 South Korea Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.3.10.3 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.3.10.4 South Korea Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4 Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027
9.4.1 Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.2 Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.2.1 Middle East & Africa Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.3 Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.4 Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.5 Middle East & Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.4.6 Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.1 Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.6.2 Saudi Arabia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.6.2.1 Saudi Arabia Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.6.3 Saudi Arabia Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.7 South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.1 South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.7.2 South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.7.2.1 South Africa Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.7.3 South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.7.4 South Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.4.8 UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.1 UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.4.8.2 UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.4.8.2.1 UAE Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.4.8.3 UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.4.8.4 UAE Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5 South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027
9.5.1 South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.2 South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.5.2.1 South and Central America Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.3 South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.5.4 South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.5 South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027, By Country (%)
9.5.6 Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.1 Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.2 Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.5.6.2.1 Argentina Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.6.3 Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.5.6.4 Argentina Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.5.7 Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.1 Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.7.2 Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.5.7.2.1 Brazil Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.5.7.3 Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.5.7.4 Brazil Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Oligonucleotide Synthesis MARKET –Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies done by the companies in the Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic developments
10.5.1 Overview
11. oligonucleotide synthesis Market–Key company profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GenScript
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Synthomics, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Ansa Biotechnologies, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Iridia, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Helixworks
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Keasling Lab
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Molecular Assemblies
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Twist Bioscience
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Evonetix
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 DNA Script
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Nuclera Nucleics Ltd.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 Camena Bio
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
list of tables
TABLE 1. North america Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 2. North America synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 3. North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 4. North America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 5. US Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 6. US synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 7. US Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 8. US Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 9. Canada Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 10. Canada synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 11. Canada Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 12. Canada Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 13. Mexico Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 14. Mexico synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 15. Mexico Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 16. Mexico Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 17. Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 18. Europe synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 19. Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 20. Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 21. UK Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 22. UK synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 23. UK Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 24. UK Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 25. Germany Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 26. Germany synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 27. Germany Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 28. Germany Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 29. France Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 30. France synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 31. France Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 32. France Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 33. Italy Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 34. Italy synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 35. Italy Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 36. Italy Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 37. Spain Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 38. Spain synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 39. Spain Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 40. Spain Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 41. Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 42. Asia Pacific synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 43. Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 44. Asia Pacific Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 45. China Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 46. China synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 47. China Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 48. China Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 49. India Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 50. India synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 51. India Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 52. India Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 53. Japan Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 54. Japan synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 55. Japan Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 56. Japan Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 57. Australia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 58. Australia synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 59. Australia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 60. Australia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 61. South Korea Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 62. South Korea synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 63. South Korea Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 64. South Korea Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 65. Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 66. Middle East & Africa synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 67. Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 68. Middle East & Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 69. Saudi Arabia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 70. Saudi Arabia synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 71. Saudi Arabia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 72. Saudi Arabia Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 73. South Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 74. South Africa synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 75. South Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 76. South Africa Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 77. UAE Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 78. UAE synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 79. UAE Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 80. UAE Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 81. South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 82. South and Central America synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 83. South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 84. South and Central America Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 85. Argentina Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 86. Argentina synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 87. Argentina Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 88. Argentina Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 89. Brazil Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By product (US$ Mn)
TABLE 90. Brazil synthesized Oligonucleotides market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 91. Brazil Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By application (US$ Mn)
TABLE 92. Brazil Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By end user (US$ Mn)
TABLE 93. Organic Developments Done By Companies
TABLE 94. Inorganic developments done by Companies
TABLE 95. Glossary of Terms, Oligonucleotide Synthesis market
list of figures
FIGURE 1. Oligonucleotide synthesis market Segmentation
FIGURE 2. oligonucleotide synthesis Segmentation, by region
FIGURE 3. Asia Pacific Oligonucleotide Synthesis market, Revenue (US$ Mn), By Geography 2018 & 2027
FIGURE 4. Global Oligonucleotide Synthesis Market By product, Market Share (%), 2018
FIGURE 5. Global Oligonucleotide Synthesis Market By application, Market Share (%), 2018
FIGURE 6. Global Oligonucleotide Synthesis Market By end user, Market Share (%), 2018
FIGURE 7. North America : PEST Analysis
FIGURE 8. Europe : PEST Analysis
FIGURE 9. Asia - Pacific : PEST Analysis
FIGURE 10. Middle East & Africa : PEST Analysis
FIGURE 11. South & Central America : PEST Analysis
FIGURE 12. oligonucleotide synthesis market impact analysis of driver and restraints
FIGURE 13. global Oligonucleotide Synthesis market – Revenue Forecasts and Analysis – 2018- 2027
FIGURE 14. global Oligonucleotide Synthesis market – by geography Forecasts and Analysis – 2018- 2027
FIGURE 15. Global Oligonucleotide synthesis market By Product, 2018 & 2027 (%)
FIGURE 16. Global Synthesized oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. Global primers Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Global Probes Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. Global Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. Global others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. Global Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 22. Global Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 23. Global Oligonucleotide synthesis market By application, 2018 & 2027 (%)
FIGURE 24. Global Research Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 26. Global therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 27. Global Oligonucleotide synthesis market By end user, 2018 & 2027 (%)
FIGURE 28. Global Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 29. Global diagnostic laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 30. Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 31. Global Other end users Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 32. North america Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 33. North america Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 34. North America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 35. US Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 36. Canada Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 37. Mexico Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 38. Europe Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 39. Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 40. Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 41. UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 42. Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 43. France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 44. Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 45. Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 46. Asia Pacific Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 47. Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 48. Asia Pacific Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 49. China Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 50. India Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 51. Japan Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 52. Australia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 53. South Korea Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 54. Middle East & Africa Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 55. Middle East & Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 56. Middle East & Africa Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 57. Saudi Arabia Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 58. South Africa Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 59. UAE Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 60. South and Central America Oligonucleotide Synthesis Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 61. South and Central America Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 62. South and Central America Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 63. Argentina Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 64. Brazil Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 65. Comparative Company Analysis
FIGURE 66. Growth Strategies done by the companies in the Market, (%)
The List of Companies
- Thermo Fisher Scientific Inc.
- GenScript
- Molecular Assemblies
- Twist Biosciences
- Evonetix
- DNA Script
- Nuclera Nucleics
- Camena Bioscience
- Synthomics
- Ansa Biotechnologies
- Helixworks
- Iridia
- Keasling Laboratories
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Oligonucleotide Synthesis Market
Mar 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2019